Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-21-026985

Options or other derivatives

  • Director acquired 181,763 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Corzo Kathryn Penkus Director 2021-11-01 Grant or award · Stock option (right to buy) +181,763 181,763 D
Loading xslF345X03/ownership.xml…